Harry Hendrikse

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study

Yves J. L. Bodar, Gerben J.C. Zwezerijnen, Patrick J. van der Voorn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 28 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging

Dennie Meijer, Pim J. van Leeuwen, Maarten L. Donswijk et al. · British Journal of Urology · 2021 · 21 citations · Full text

Medicine, Oncology, Surgery +17

PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study

Sanne A. M. van Lith, Ilanah J. Pruis, Nelleke Tolboom et al. · Journal of Nuclear Medicine · 2023 · 18 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging

Eveline Annette van de Stadt, Maqsood Yaqub, Adriaan A. Lammertsma et al. · Lung Cancer · 2021 · 15 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients

Eveline Annette van de Stadt, Maqsood Yaqub, Robert C. Schuit et al. · Diagnostics · 2022 · 15 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +16